CyDex Pharmaceuticals Report issue

For profit
Founded: Lenexa KS United States (1993)
Status: Acquired by Ligand Pharmaceuticals (2011)

Organization Overview

First Clinical Trial
2019
NCT03869983
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CyDex Pharmaceuticals, Inc.

Active Ingredients

Drugs in Other Trials (2)

hydroxypropyl-beta-cyclodextrin (1 trial)

iohexol (Omnipaque) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2